Invited Reviews
Question of an Infectious Etiology or Contribution to the Pathogenesis of Infantile Hypertrophic Pyloric Stenosis
Taher Modarressi,
Corresponding Author
Taher Modarressi
Department of Internal Medicine, Massachusetts General Hospital, Boston, MA
Address correspondence and reprint requests to Taher Modarressi, MD, Department of Internal Medicine, 55 Fruit Street, GRB 740, Boston, MA 02114 (e-mail: [email protected]).Search for more papers by this authorTaher Modarressi,
Corresponding Author
Taher Modarressi
Department of Internal Medicine, Massachusetts General Hospital, Boston, MA
Address correspondence and reprint requests to Taher Modarressi, MD, Department of Internal Medicine, 55 Fruit Street, GRB 740, Boston, MA 02114 (e-mail: [email protected]).Search for more papers by this authorThe author reports no conflicts of interest.
ABSTRACT
Infantile hypertrophic pyloric stenosis is a concerning cause of nonbilious vomiting in the neonatal population. Although a number of etiological theories exist, its exact cause remains nebulous. The question of an infectious etiology (or contribution) has been previously examined in case reports and case series, with recent support through suggestions of seasonality and familial aggregation with unclear inheritance patterns. The present review discusses the published literature regarding infectious etiologies of infantile hypertrophic pyloric stenosis. Furthermore, it attempts to demonstrate that newer research regarding an NOS1 genetic etiology does not exclude, but rather can be consistent with, an infectious etiology.
REFERENCES
- 1Panteli C. New insights into the pathogenesis of infantile pyloric stenosis. Pediatr Surg Int 2009; 25: 1043–1052.
- 2Peeters B, Benninga MA, Hennekam RC. Infantile hypertrophic pyloric stenosis: genetics and syndromes. Nat Rev Gastroenterol Hepatol 2012; 9: 646–660.
- 3Schechter R, Torfs CP, Bateson TF. The epidemiology of infantile hypertrophic pyloric stenosis. Paediatr Perinat Epidemiol 1997; 11: 407–427.
- 4Mackay AJ, Mackellar A. Infantile hypertrophic pyloric stenosis: a review of 222 cases. Austral N Z J Surg 1986; 56: 131–133.
- 5Zamakhshary MF, Dutta S, To T, et al. Seasonal variation of hypertrophic pyloric stenosis: a population-based study. Pediatr Surg Int 2011; 27: 689–693.
- 6Kwok RH, Avery G. Seasonal variation of hypertrophic pyloric stenosis. J Pediatr 1967; 70: 963–965.
- 7Dodge JA. Infantile hypertrophic pyloric stenosis in Belfast, 1957-1969. Arch Dis Child 1975; 50: 171–178.
- 8Habbick BF, To T. Incidence of infantile hypertrophic pyloric stenosis in Saskatchewan, 1970-85. CMAJ 1989; 140: 395–398.
- 9Leong MM, Chen SC, Hsieh CS, et al. Epidemiological features of infantile hypertrophic pyloric stenosis in Taiwanese children: a nation-wide analysis of cases during 1997-2007. PLoS One 2011; 6: e19404.
- 10Johnston D, Lyndon PJ, Smith RB, et al. Highly selective vagotomy without a drainage procedure in the treatment of haemorrhage, perforation, and pyloric stenosis due to peptic ulcer. Br J Surg 1973; 60: 790–797.
- 11Rigler S, Oberhelman H Jr, Brasher P, et al. Pyloric stenosis and gastric ulcer. AMA Arch Surg 1955; 71: 191–195.
- 12Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 323: 1311–1315.
10.1016/S0140-6736(84)91816-6 Google Scholar
- 13de Boer WA, Driessen WM. Resolution of gastric outlet obstruction after eradication of Helicobacter pylori. J Clin Gastroenterol 1995; 21: 329–330.
- 14Tursi A, Cammarota G, Papa A, et al. Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis. J Clin Gastroenterol 1996; 23: 157–158.
- 15Moon S, Shim Y, Lee N, et al. The relationship between Helicobacter pylori infection and infantile hypertrophic pyloric stenosis in infants. J Korea Surg Soc 1994; 46: 724–731.
- 16Paulozzi LJ. Is Helicobacter pylori a cause of infantile hypertrophic pyloric stenosis? Med Hypotheses 2000; 55: 119–125.
- 17Aslanabadi S, Rafeey M, Diaz D, et al. Role of Helicobacter pylori in the pathogenesis of infantile hypertrophic pyloric stenosis. Afr J Paediatr Surg 2011; 8: 172–175.
- 18Dahshan A, Donovan KG, Halabi IM, et al. Helicobacter pylori and infantile hypertrophic pyloric stenosis: is there a possible relationship? J Pediatr Gastroenterol Nutr 2006; 42: 262–264.
- 19Sherwood W, Choudhry M, Lakhoo K. Infantile hypertrophic pyloric stenosis: an infectious cause? Pediatr Surg Int 2007; 23: 61–63.
- 20Alarotu H. The histopathologic changes in the myenteric plexus of the pylorus in hypertrophic pyloric stenosis of infants (pylorospasm). Acta Paediatr Suppl 1956; 45: 1–131.
- 21Herweg JC, Middelkamp JN, Thornton HK, et al. A search into the etiology of hypertrophic pyloric stenosis. J Pediatr 1962; 61: 309–310.
- 22Dionne JM, Carter JE, Matsell D, et al. Renal leiomyoma associated with Epstein-Barr virus in a pediatric transplant patient. Am J Kid Dis 2005; 46: 351–355.
- 23Hatano M, Takada H, Nomura A, et al. Epstein-Barr virus-associated bronchial leiomyoma in a boy with cellular immunodeficiency. Pediatr Pulmonol 2006; 41: 371–373.
- 24Jenson HB, Gulley ML, Puri P. Absence of Epstein-Barr virus in smooth muscle cells of idiopathic hypertrophic pyloric stenosis. Arch Pathol Lab Med 2001; 125: 361–363.
- 25McHeik JN, Dichamp I, Levard G, et al. Infantile hypertrophic pyloric stenosis: are viruses involved? J Med Virol 2010; 82: 2087–2091.
- 26Joo MK, Park JJ, Lee BJ, et al. A case of stenotic change from gastric candidiasis managed with temporary stent insertion. Gut Liver 2011; 5: 238–241.
- 27Goenka M, Kochhar R, Chakrabarti A, et al. Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole. J Clin Gastroenterol 1996; 23: 7–10.
- 28Agunod M, Yamaguchi N, Lopez R, et al. Correlative study of hydrochloric acid, pepsin, and intrinsic factor secretion in newborns and infants. Am J Dig Dis 1969; 14: 400–413.
- 29Avery GB, Randolph JG, Weaver T. Gastric acidity in the first day of life. Pediatrics 1966; 37: 1005–1007.
- 30Ozturk G, Aydinli B, Celebi F, et al. Gastric perforation caused by Strongyloides stercoralis: a case report. Ulus Travma Acil Cerrahi Derg 2011; 17: 90–92.
- 31Cui W, Ma CX, Tang Y, et al. Sex differences in birth defects: a study of opposite-sex twins. Birth Defects Res A Clin Mol Teratol 2005; 73: 876–880.
- 32To T, Wajja A, Wales PW, et al. Population demographic indicators associated with incidence of pyloric stenosis. Arch Pediatr Adolesc Med 2005; 159: 520–525.
- 33Green MS. The male predominance in the incidence of infectious diseases in children: a postulated explanation for disparities in the literature. Int J Epidemiol 1992; 21: 381–386.
- 34Schlegel RJ, Bellanti JA. Increased susceptibility of males to infection. Lancet 1969; 2: 826–827.
- 35Washburn TC, Medearis DN, Childs B. Sex differences in susceptibility to infections. Pediatrics 1965; 35: 57–64.
- 36Fortunov RM, Hulten KG, Hammerman WA, et al. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics 2006; 118: 874–881.
- 37Shah S, Sharieff GQ. Pediatric respiratory infections. Emerg Med Clin North Am 2007; 25: 961–979.
- 38Thompson DJ, Gezon HM, Rogers KD, et al. Excess risk of staphylococcal infection and disease in newborn males. Am J Epidemiol 1966; 84: 314–328.
- 39Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011; 96: F9–F14.
- 40Biyikli NK, Alpay H, Ozek E, et al. Neonatal urinary tract infections: analysis of the patients and recurrences. Pediatr Int 2004; 46: 21–25.
- 41Zuk M, McKean KA. Sex differences in parasite infections: patterns and processes. Int J Parasitol 1996; 26: 1009–1024.
- 42McClelland EE, Smith JM. Gender specific differences in the immune response to infection. Arch Immunol Ther Exp (Warsz) 2011; 59: 203–213.
- 43Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol 2010; 10: 594–604.
- 44Chung E. Infantile hypertrophic pyloric stenosis: genes and environment. Arch Dis Childhood 2008; 93: 1003–1004.
- 45Friebe A, Koesling D. The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models. Nitric Oxide 2009; 21: 149–156.
- 46Huang LT, Tiao MM, Lee SY, et al. Low plasma nitrite in infantile hypertrophic pyloric stenosis patients. Dig Dis Sci 2006; 51: 869–872.
- 47Kusafuka T, Puri P. Altered messenger RNA expression of the neuronal nitric oxide synthase gene in infantile hypertrophic pyloric stenosis. Pediatr Surg Int 1997; 12: 576–579.
- 48Vanderwinden JM, Mailleux P, Schiffmann SN, et al. Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. N Engl J Med 1992; 327: 511–515.
- 49Adler HS, Simon A, Graulich E, et al. Neuronal nitric oxide synthase modulates maturation of human dendritic cells. J Immunol 2010; 184: 6025–6034.
- 50Nagy G, Clark JM, Buzás EI, et al. Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett 2007; 111: 1–5.
- 51Jarazo-Dietrich S, Jacobo P, Pérez CV, et al. Up regulation of nitric oxide synthase-nitric oxide system in the testis of rats undergoing autoimmune orchitis. Immunobiology 2012; 217: 778–787.
- 52Colasanti M, Cavalieri E, Persichini T, et al. Bacterial lipopolysaccharide plus interferon-gamma elicit a very fast inhibition of a Ca2+-dependent nitric-oxide synthase activity in human astrocytoma cells. J Biol Chem 1997; 272: 7582–7585.
- 53Colasanti M, Persichini T, Cavalieri E, et al. Rapid inactivation of NOS-I by lipopolysaccharide plus interferon-gamma-induced tyrosine phosphorylation. J Biol Chem 1999; 274: 9915–9917.
- 54Colasanti M, Suzuki H. The dual personality of NO. Trends Pharmacol Sci 2000; 21: 249–252.
- 55Matthews JR, Botting CH, Panico M, et al. Inhibition of NF-κB DNA binding by nitric oxide. Nucl Acids Res 1996; 24: 2236–2242.
- 56Togashi H, Sasaki M, Frohman E, et al. Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression. Proc Natl Acad Sci U S A 1997; 94: 2676–2680.
- 57Akaike T, Weihe E, Schaefer M, et al. Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. J Neurovirol 1995; 1: 118–125.
- 58Ovadia H, Rosenmann H, Shezen E, et al. Effect of scrapie infection on the activity of neuronal nitric-oxide synthase in brain and neuroblastoma cells. J Biol Chem 1996; 271: 16856–16861.
- 59Fatemi SH, Cuadra AE, El-Fakahany EE, et al. Prenatal viral infection causes alterations in nNOS expression in developing mouse brains. Neuroreport 2000; 11: 1493–1496.
- 60Hayashi T, Yamada K, Esaki T, et al. Effect of estrogen on isoforms of nitric oxide synthase: possible mechanism of anti-atherosclerotic effect of estrogen. Gerontology 1997; 43 (suppl 1): 24–34.
Citing Literature
